Menu
  • Join
  • Login
  • Contact
 

Search abstracts


The impact of dissolution in the lower intestine on the absorption of high dose low solubility drugs

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: VERTZONI, Maria (National and Kapodistrian University of Athens, Pharmacy, Athens, Greece)
  • Co-author(s): Danai Georgaka: Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
    James Butler: Product Development, GlaxoSmithKline, Ware, United Kingdom
    Filippos Kesisoglou: Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc., Kenilworth, United States
    Christos Reppas: Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
    Maria Vertzoni: Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
  • Abstract:

    Backgrounds

    This work was performed within the OrBiTo project funded by the IMI Joint Undertaking under Grant Agreement No 115369.

    Aims

    Τo evaluate the impact of dissolution in the lower intestine on the absorption of three model, high dose, low solubility drugs, i.e. micronized aprepitant, SB705498 [Immediate release tablets (25mg/tab) and Capsules

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses